Saturday, September 26, 2026
MiningNewsTerminal
Saturday, September 26, 2026 Admin

OGN.V ·

Orogen Options Manhattan Gap to Stampede Metals

Mergers & Acquisitions

Orogen Options Manhattan Gap to Stampede

Metals

VANCOUVER, BC

,

April 27, 2021

/CNW/ -

(TSXV: OGN) Orogen Royalties Inc. ("Orogen" or the

"Company") is pleased to announce that it has signed an option agreement (the "Agreement") with

Stampede Metals Corp. ("Stampede"), a private

Nevada

company, whereby Stampede can acquire

a 100% interest in the Manhattan Gap porphyry/polymetallic carbonate replacement project in

eastern

Nevada

, USA. To earn a 100% interest in Manhattan Gap, Stampede will make a cash

payment of

US$18,243

, issue 7.5% of Stampede's shares outstanding (approximately

US$158,000

in value), incur up to 7,500 metres of drilling over a six-year period, and grant to Orogen a 1.5% net

smelter return ("NSR") royalty.

"Part of Orogen's value and royalty creation strategy is to use exploration alliances and joint

ventures to advance our property portfolio toward exploration discovery," commented Orogen CEO

Paddy Nicol

. "Our flagship royalty assets Ermitaño and Silicon were created in this manner and

having eight active partner-funded joint ventures and alliances increases our opportunity for

additional royalties. We welcome Stampede Metals' option on the Manhattan Gap project and look

forward to their exploration programs in 2021."

About the Manhattan Gap Project

The Manhattan Gap project is a porphyry and polymetallic carbonate replacement target located in

the historic

Pioche

mining district in

Lincoln County

, Nevada. Multiple target areas exist in the district

associated with a large zoned Cretaceous porphyry system that has been tilted and dismembered

by post-mineral faulting (Figure 1). By combining Orogen's 8.2 square kilometre land package with

Stampede Metals' 8.5 square kilometre land package, the project can be explored effectively as a

unified district-scale project.

Orogen's claim block covers a four-kilometre-long polymetallic fissure vein swarm hosted in

Cambrian and Ordovician carbonates. The vein swarm is preserved in a down-dropped graben,

which extends from the Manhattan Stock to the eastern edge of exposures with rock samples

returning <0.005 to 4.9 grams per tonne ("g/t") gold, <0.1 to 422 g/t silver, and <0.005 to 1%

copper. A possible igneous source for mineralizing fluids is the porphyritic Manhattan Stock

complex, which occurs just west of Orogen's claim block within Stampede Metals' project area. The

top of the Manhattan Stock has been cut off by the Lucky Boy Fault and the hanging wall portion of

the porphyry has not been identified. Multiple targets exist in the hanging wall of the Lucky Boy Fault

including the West Graben Target on Orogen's claim block. This target is defined by a spatially

coincident gravity low and magnetic high in an alluvial covered basin (Figure 2). Recent IP work

carried out by Stampede Metals has identified a high resistivity -and high chargeability anomaly in

the West Graben Target. The geophysical signature of this target is similar in size and style to that

of the breccia pipes hosting the Peñasquito deposit in the Sierra Madre Oriental in

Mexico

(12.7

million ounces gold, 527 million ounces silver, 3,600 million pounds lead, 8,000 million pounds zinc)

1

.

Stampede Metals is planning a 6,000 metre drilling program for 2021 to explore for porphyry-style

copper-gold mineralization. The program will include a minimum of 500 metres of drilling on

Orogen's West Graben Target.

Figure 1: Location of the Manhattan Gap project in Lincoln County, Nevada. (CNW Group/Orogen

Royalties Inc.)

Figure 2: West Basin Target showing traced outlines of gravity low and coincident magnetic highs in

covered area.

IP line A-A’ shown identifying conductivity anomaly on north margin of target. (CNW

Group/Orogen Royalties Inc.)

Terms of the Manhattan Gap Option Agreement

Stampede can earn a 100% interest in the Manhattan Gap project subject to the following terms:

Cash payment on signing of

US$18,243

;

Equity interest of 7.5% of the capital structure of Stampede;

A minimum of 500 metres of drilling prior to the first anniversary from the date of the

Agreement; and

A minimum of 7,500 metres of drilling prior to the sixth anniversary from the date of the

Agreement.

In the event Stampede has not completed the 7,500 metres on the sixth anniversary, Stampede will

make a cash payment of

US$500,000

to Orogen. Upon commencement of commercial production,

Stampede will pay to Orogen

US$2.50

per gold-equivalent ounces classified as Mineral Reserves

under JORC (2012) guidelines.

Stampede will also grant a 1.5% NSR royalty to Orogen.

Qualified Person Statement

All technical data, as disclosed in this press release, has been verified by the Company's qualified

person Mr.

Daniel Pace

, M.Sc., Vice President of Exploration, who is Registered Member 4202658

of the Society for Mining, Metallurgy and Exploration.

About Orogen Royalties Inc.

Orogen Royalties Inc. is engaged in project generation for precious and base metal discoveries in

western

North America

with a focus on organic royalty creation and royalty acquisitions. Orogen's

royalty portfolio includes the Ermitaño West gold deposit in

Sonora, Mexico

(2% NSR) being

developed by First Majestic Silver Corp. and the Silicon gold project (1% NSR) in

Nevada, USA

,

being advanced by AngloGold Ashanti N.A. The Company is well financed with several projects

actively being developed by joint venture partners.

On Behalf of the Board

OROGEN ROYALTIES INC.

Paddy Nicol

President & CEO

Visit our website at

www.orogenroyalties.com

.

Orogen Royalties Inc.

1201 - 510 West Hastings Street

Vancouver, BC

Canada

V6B 1L8

[email protected]

1.

Dromundo et. Al. 2020, The Peñasquito Gold-(Silver-Lead-Zine) Deposit, Zacatecas, Mexico, Society of Economic

Geology Special Publication no. 23. Pp. 399-414.

Forward Looking Information

This news release includes certain statements that may be deemed "forward looking statements".

All statements in this presentation, other than statements of historical facts, that address events or

developments that Orogen Royalties Inc. (the "Company") expect to occur, are forward looking

statements. Forward looking statements are statements that are not historical facts and are

generally, but not always, identified by the words "expects", "plans", "anticipates", "believes",

"intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions

"will", "would", "may", "could" or "should" occur.

Forward looking information relates to statements concerning the Company's future outlook and

anticipated events or results, as well as the Company's management expectations with respect to

the proposed business combination (the "Transaction"). This document also contains forward-looking

statements regarding the anticipated completion of the Transaction and timing thereof. Forward-

looking statements in this document are based on certain key expectations and assumptions made

by the Company, including expectations and assumptions concerning the receipt, in a timely manner,

of regulatory and stock exchange approvals in respect of the Transaction.

Although the Company believe the expectations expressed in such forward looking statements are

based on reasonable assumptions, such statements are not guarantees of future performance and

actual results may differ materially from those in the forward looking statements. Factors that could

cause the actual results to differ materially from those in forward looking statements include market

prices, exploitation and exploration successes, and continued availability of capital and financing, and

general economic, market or business conditions. Furthermore, the extent to which COVID-19 may

impact the Company's business will depend on future developments such as the geographic spread

of the disease, the duration of the outbreak, travel restrictions, physical distancing, business

closures or business disruptions, and the effectiveness of actions taken in

Canada

and other

countries to contain and treat the disease. Although it is not possible to reliably estimate the length

or severity of these developments and their financial impact as of the date of approval of these

condensed interim consolidated financial statements, continuation of the prevailing conditions could

have a significant adverse impact on the Company's financial position and results of operations for

future periods.

Investors are cautioned that any such statements are not guarantees of future performance and

actual results or developments may differ materially from those projected in the forward looking

statements. Forward looking statements are based on the beliefs, estimates and opinions of the

Company's management on the date the statements are made. Except as required by securities

laws, the Company undertakes no obligation to update these forward looking statements in the event

that management's beliefs, estimates or opinions, or other factors, should change.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the

policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this

release

SOURCE

Orogen Royalties Inc.

View original content to download multimedia:

http://www.newswire.ca/en/releases/archive/April2021/27/c2991.html

%SEDAR: 00027260E

For further information:

To find out more about Orogen, please contact Paddy Nicol, President &

CEO at 604-248-8648, and Liliana Wong, Manager of Marketing and Investor Relations at 604-248-

8648.

CO: Orogen Royalties Inc.

CNW 07:00e 27-APR-21